…along came The Monkeypox virus!
Symptoms may include a desire to swing from tree to tree, to pick breakfast bugs off your mate, and to screech, yell, and generally monkey around. But seriously….
According to the Centers for Disease Creation (CDC), the agency that created at least eight Genus categories of Pox Diseases, Monkeypox is called a “rare disease.” However, Monkeypox cannot be considered “rare,” if the CDC also claims that Monkeypox is spreading.
Before anyone could say Monkeypox jjab patent, the U.S. government swooped in to purchase over $100 million in jjabs to treat both Monkeypox and Smallpox.
After all, where there is a will, there is a jjab patent!
In February 2021, patent application #20210260182 was filed for RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS. This is a combination pox/COVID jjab patent filed over a year ago:
The terms “chimeric” or “engineered” or “modified” (e.g., chimeric poxvirus, engineered polypeptide, modified polypeptide, engineered nucleic acid, modified nucleic acid) or grammatical variations thereof are used interchangeably herein to refer to a non-native sequence that has been manipulated to have one or more changes relative a native sequence.
In some embodiments, the SARS-CoV-2 protein is inserted into the Thymidine Kinase (TK) locus (Gene ID HPXV095; positions 992077-92610; SEQ ID NO: 1) of the horsepox virus or the synthetic horsepox virus.
Then came the newly patented pox-combo Omicron jjab. Of course, other labs are developing tests for Monkeypox virus. Get ready for the temperature checks. You know the routine....<<<Read More>>>...